Xiaoping Bao
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
Publications
91
Citations
4,729
Est. group size
~9
Recurring co-author estimate
Active years
15
Publishing since 2012
Xiaoping Bao's research focuses on engineering human pluripotent stem cells (versatile cells that can become nearly any cell type in the body) for use in disease modeling, drug screening, and cell-based therapies. Work spans gene-editing tools, optogenetics (using light to control cell signaling), bioreactor-based manufacturing, and engineered immune cell therapies such as CAR-T cells for cancer and hypoimmunogenic cells for transplantation. The lab combines molecular biology, bioengineering, and materials science approaches to make stem-cell-derived tissues and therapies more precise, scalable, and clinically usable.
Publication output has grown from a handful of papers in 2017-2018 to a peak of around 12 in 2022, followed by a modest decline through 2025-2026, suggesting an overall increase in activity over the decade with some recent slowing.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- A vCD Peptide Module Enables Potent dCas12a Transcriptional Activation in Human Pluripotent Stem Cells
SSRN Electronic Journal · 2026
- Engineering CAR‐T Therapeutics for Enhanced Solid Tumor Targeting
Advanced Materials · 2025
- Forward programming of hPSCs to neutrophils using chemically defined media
Stem Cell Research & Therapy · 2025
- Hypoimmunogenic hPSC-derived cardiac organoids for immune evasion and heart repair
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Effects of Lactobacillus plantarum (L) and molasses (M) on nutrient composition, aerobic stability, and microflora of alfalfa silage in sandy grasslands
Frontiers in Microbiology · 2024
- Profiling biomanufactured extracellular vesicles of human forebrain spheroids in a Vertical‐Wheel Bioreactor
Journal of Extracellular Biology · 2024
- MAGIK: A rapid and efficient method to create lineage-specific reporters in human pluripotent stem cells
Stem Cell Reports · 2024
- Optogenetic control of Wnt signaling models cell-intrinsic embryogenic patterning using 2D human pluripotent stem cell culture
Development · 2023
- Editorial: Bioengineered gene and cell therapy for treating cardiovascular diseases
Frontiers in Bioengineering and Biotechnology · 2023
- MAGIK: A rapid and efficient method to create lineage-specific reporters in human pluripotent stem cells
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- Robust genome editing via modRNA-based Cas9 or base editor in human pluripotent stem cells
Cell Reports Methods · 2022
- Robust genome editing via modRNA-based Cas9 or base editor in human pluripotent stem cells
bioRxiv (Cold Spring Harbor Laboratory) · 2022
- Generation of pancreatic progenitors from human pluripotent stem cells by small molecules
Stem Cell Reports · 2021
- A dual cardiomyocyte reporter model derived from human pluripotent stem cells
Stem Cell Research & Therapy · 2021
- Review for "Optimization of the Nutritional Environment for Differentiation of Human Induced Pluripotent Stem Cells using Design of Experiments - A Proof of Concept"
2021
- bioRxiv (Cold Spring Harbor Laboratory)×10
- Bioactive Materials×5
- Scientific Reports×4
- SSRN Electronic Journal×4
- Advanced Materials×3
- Ryan Hicks
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Yun Chang
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Qi Zhou
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Mark E. Hester
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Ji‐Dong Fu
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile